34
Participants
Start Date
October 31, 2009
Primary Completion Date
December 31, 2013
Study Completion Date
February 28, 2015
REOLYSIN
1E10 TCID50, 1-hour intravenous infusion on Days 1 and 2 and then Days 8 and 9 of a 21-day cycle.
Gemcitabine
800 mg/m2 30-min infusion on Days 1 and 8 of a 21-day cycle.
Montefiore Medical Center, New York
Cancer Therapy & Research Center at UTHSCSA, San Antonio
Lead Sponsor
University of Texas
OTHER
Oncolytics Biotech
INDUSTRY